Literature DB >> 10550658

Protective effects of memantine against ischemia-reperfusion injury in spontaneously hypertensive rats.

A Dogan1, M A Eras, V L Rao, R J Dempsey.   

Abstract

Memantine, an uncompetitive NMDA open-channel blocker, has been shown to be effective in preventing neuronal damage after permanent focal cerebral ischemia. Reperfusion after a long period of ischemia may aggravate the progression of neuronal damage. Those drugs that show protective effects after permanent cerebral ischemia, therefore, might fail to do so against ischemia-reperfusion injury. In this study we evaluated the effects of memantine on brain edema formation and ischemic injury volume after transient cerebral ischemia. Male Spontaneously Hypertensive Rats (SHR) weighing 250-300 g were anesthetized with halothane and subjected to 1 hour of temporary middle cerebral artery occlusion by an intraluminal suture. 20 mg/kg of memantine or saline were injected intraperitoneally 5 min. after the induction of ischemia. Physiological parameters and regional cerebral blood flow were monitored during the surgical procedure. Brain water content and ischemic injury volume were measured with the wet dry method and 2,3,5-triphenyl tetrazolium chloride monohydrate (TTC) staining, respectively, at 24 hours after occlusion. There were no statistically significant differences between the groups regarding physiological parameters during the procedure. Memantine treatment (n=9) reduced the brain water content significantly in the cortex compared to saline treatment (n=8; 83. 1+/-0.7% vs. 84.5+/-1.5%, respectively, p<0.05). The total volume of ischemic brain injury was 300+/-49 mm(3) in the animals treated with saline (n=13). Treatment with 20 mg/kg memantine (n=14) reduced the ischemic injury volume to 233+/-61 mm(3) (P<0.01). These results demonstrate that the harmful effects of recirculation after a period of ischemia can be attenuated by the treatment of memantine, perhaps by its action at the NMDA receptors.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10550658     DOI: 10.1007/s007010050491

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  9 in total

1.  NMDA receptor antagonism does not inhibit induction of ischemic tolerance in gerbil brain in vivo.

Authors:  M Duszczyk; R Gadamski; A Ziembowicz; W Danysz; J W Lazarewicz
Journal:  Neurotox Res       Date:  2005       Impact factor: 3.911

Review 2.  Memantine.

Authors:  Blair Jarvis; David P Figgitt
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

3.  Novel neuroprotective mechanisms of memantine: increase in neurotrophic factor release from astroglia and anti-inflammation by preventing microglial activation.

Authors:  Hung-Ming Wu; Nian-Sheng Tzeng; Li Qian; Sung-Jen Wei; Xiaoming Hu; Shih-Heng Chen; Scott M Rawls; Patrick Flood; Jau-Shyong Hong; Ru-Band Lu
Journal:  Neuropsychopharmacology       Date:  2009-06-17       Impact factor: 7.853

4.  Protease-activated receptor 1-dependent neuronal damage involves NMDA receptor function.

Authors:  Cecily E Hamill; Guido Mannaioni; Polina Lyuboslavsky; Aristide A Sastre; Stephen F Traynelis
Journal:  Exp Neurol       Date:  2009-02-10       Impact factor: 5.330

5.  Study of the neuroprotective effects of memantine in patients with mild to moderate ischemic stroke.

Authors:  Hamidreza Kafi; Jamshid Salamzadeh; Nahid Beladimoghadam; Mohammad Sistanizad; Mehran Kouchek
Journal:  Iran J Pharm Res       Date:  2014       Impact factor: 1.696

6.  Memantine improves semantic memory in patients with amnestic mild cognitive impairment: A single-photon emission computed tomography study.

Authors:  Demet Ilhan Algin; Suna Dagli Atalay; Serhat Ozkan; Demet Ozbabalik Adapinar; Ilknur Ak Sivrioz
Journal:  J Int Med Res       Date:  2017-06-29       Impact factor: 1.671

7.  Pharmacodynamics of memantine: an update.

Authors:  G Rammes; W Danysz; C G Parsons
Journal:  Curr Neuropharmacol       Date:  2008-03       Impact factor: 7.363

8.  Memantine inhibits α3β2-nAChRs-mediated nitrergic neurogenic vasodilation in porcine basilar arteries.

Authors:  Reggie Hui-Chao Lee; Ting-Yi Tseng; Celeste Yin-Chieh Wu; Po-Yi Chen; Mei-Fang Chen; Jon-Son Kuo; Tony Jer-Fu Lee
Journal:  PLoS One       Date:  2012-07-05       Impact factor: 3.240

9.  Allograft of Sertoli Cell Transplantation in Combination with Memantine Alleviates Ischemia-Induced Tissue Damages in An Animal Model of Rat.

Authors:  Zeinab SafialHosseini; Mohammadreza Bigdeli; Sepideh Khaksar; Abbas Aliaghaei
Journal:  Cell J       Date:  2019-12-15       Impact factor: 2.479

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.